ST6GALNAC3
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
Also known as: SIA7C_HUMAN, SIAT7C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NDV1
- Gene
- ST6GALNAC3
- Ensembl
- ENSG00000184005
- Chromosome
- 1
- Canonical length
- 305 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
ST6GALNAC3 belongs to a family of sialyltransferases that transfer sialic acids from CMP-sialic acid to terminal positions of carbohydrate groups in glycoproteins and glycolipids (Lee et al., 1999 [PubMed 10207017]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
305 residues, UniProt reviewed canonical sequence.
>Q8NDV1|ST6GALNAC3
1 MACILKRKSV IAVSFIAAFL FLLVVRLVNE VNFPLLLNCF GQPGTKWIPF SYTYRRPLRT
61 HYGYINVKTQ EPLQLDCDLC AIVSNSGQMV GQKVGNEIDR SSCIWRMNNA PTKGYEEDVG
121 RMTMIRVVSH TSVPLLLKNP DYFFKEANTT IYVIWGPFRN MRKDGNGIVY NMLKKTVGIY
181 PNAQIYVTTE KRMSYCDGVF KKETGKDRVQ SGSYLSTGWF TFLLAMDACY GIHVYGMIND
241 TYCKTEGYRK VPYHYYEQGR DECDEYFLHE HAPYGGHRFI TEKKVFAKWA KKHRIIFTHP
301 NWTLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ST6GALNAC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 13 nTPM
- spinal cord: 9.6 nTPM
- kidney: 8.1 nTPM
- adipose tissue: 7.5 nTPM
- choroid plexus: 6.2 nTPM
- tongue: 6.1 nTPM
Single-cell type
- podocytes: 8,623 nCPM
- neutrophils: 3,520 nCPM
- microglia: 2,471 nCPM
- choroid plexus epithelial cells: 1,708 nCPM
- neutrophil progenitors: 1,413 nCPM
- lymphatic endothelial cells: 1,236 nCPM
Immune cell
- classical monocyte: 6.3 nTPM
- non-classical monocyte: 4.4 nTPM
- neutrophil: 3.9 nTPM
- naive B-cell: 3.8 nTPM
- eosinophil: 2.8 nTPM
- memory B-cell: 2.6 nTPM
Brain region
- white matter: 48 nTPM
- medulla oblongata: 42 nTPM
- cerebellum: 36 nTPM
- pons: 36 nTPM
- spinal cord: 34 nTPM
- basal ganglia: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ST6GALNAC3.
Disease | ImmuneIEDB
Conditions an epitope on ST6GALNAC3 was assayed in.
- viral infectious disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ganglioside biosynthetic process
- glycoprotein metabolic process
- glycosphingolipid metabolic process
- glycosylceramide metabolic process
- oligosaccharide metabolic process
- viral protein processing
Molecular functions
- alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity
- alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity
- sialyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ST6GALNAC3 as an antibody target. Whether an autoantibody or antibody against ST6GALNAC3 could matter depends on whether native ST6GALNAC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ST6GALNAC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ST6GALNAC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...